Highlights of the fourth ACCP Task Force on Antithrombotic Therapy James E. Dalen OriginalPaper Pages: 261 - 264
Management of anticoagulant therapy: The dutch experience Frits R. RosendaalFelix J. M. van der MeerSuzanne C. Cannegieter OriginalPaper Pages: 265 - 269
Recognition and management of the hypercoagulable states: A decade of change Scott H. GoodnightThomas G. DeLougheryRichard D. Press OriginalPaper Pages: 271 - 274
Thrombolysis for acute pulmonary embolism: Are the risks worth the benefits? C. Gregory Elliott OriginalPaper Pages: 275 - 278
Low molecular weight heparin in the prevention and treatment of venous thromboembolism Gary E. Raskob OriginalPaper Pages: 279 - 284
Newer antithrombotic agents: Potential for clinical use in venous and arterial thrombosis Barbara Marie AlvingAndrew J. Carter OriginalPaper Pages: 285 - 288
Workshop: Special problems in anticoagulation therapy: Cancer and venous thromboembolism-temporary discontinuation of warfarin for surgery and invasive procedures Sally LokenJill E. AllenBarry M. Stults OriginalPaper Pages: 289 - 293
Workshop: Warfarin drug interactions: Detection, prediction, prevention Ann K. Wittkowsky OriginalPaper Pages: 295 - 299
Workshop: Data management for a 2000-patient anticoagulation clinic Lynn B. OertelMartha E. Lake OriginalPaper Pages: 305 - 307
Workshop: Prospective comparative evaluation of computer programs for the management of warfarin Leon PollerDavid Wright OriginalPaper Pages: 309 - 314
Workshop: Anticoagulation clinic care versus routine medical care: A review and interim report Henry I. BusseyElaine ChiquetteMary G. Amato ReviewPaper Pages: 315 - 319
Post-conference session: Experience with patient self-management of oral anticoagulation Angelika Bernardo OriginalPaper Pages: 321 - 325
